Lipaglyn 4 mg (Saroglitazar)

What Is Lipaglyn 4 mg (Saroglitazar)?

Lipaglyn 4 mg (Saroglitazar) is a prescription tablet manufactured by Zydus Lifesciences. It is approved in India for non-alcoholic fatty liver disease (NAFLD) — a condition where excess fat builds up in the liver of people who drink little or no alcohol.

Saroglitazar is the active ingredient. This article is general information only, and you should always consult your doctor or pharmacist before starting any medicine.

Lipaglyn is not currently registered with Australia’s Therapeutic Goods Administration (TGA), so it should only be accessed through a doctor or a legitimate pharmacy rather than an unverified online seller. Visit GenericMedsAustralia.com for further product details.

How Does Saroglitazar Work?

Saroglitazar 4 mg is a dual PPAR agonist. It activates two proteins, PPAR-alpha and PPAR-gamma, which regulate how the body uses fats and sugar.

PPAR-Alpha and Blood Fats

PPAR-alpha activation lowers blood fats, particularly triglycerides, easing the fatty burden on the liver.

PPAR-Gamma and Insulin Sensitivity

PPAR-gamma activation enhances the body’s response to insulin, improving how cells use glucose. Together, these effects may reduce liver fat and improve liver enzyme levels, which is why Saroglitazar has been studied in fatty liver disease.

What Is Lipaglyn 4 mg Used For?

Lipaglyn 4 mg uses in India include treating two related conditions.

NASH and NAFLD

It is used for non-alcoholic steatohepatitis (NASH) and non-alcoholic fatty liver disease (NAFLD), alongside diet, exercise, and weight management under a doctor’s care.

Diabetic Dyslipidaemia

Lipaglyn Tablet is also licensed for managing high blood fats in people with type 2 diabetes, known as diabetic dyslipidaemia.

Benefits of Lipaglyn 4 mg

Metabolic Benefits

• Dual pathway action: targets both PPARα and PPARγ, acting on lipid and glucose metabolism.
• Metabolic support: may help manage triglycerides and glucose levels when prescribed for an authorised indication.

Practical Benefits

• Convenient strength: a once-daily 4 mg tablet, though dosing should still be individually assessed.
• Monitoring opportunity: treatment encourages regular liver, kidney, glucose and lipid checks.

Dosage and Administration

Per the Indian product information, the Lipaglyn 4 mg dosage is one tablet daily; your doctor decides the dose and duration for your condition.

General Guidelines

• Follow your doctor’s and pharmacist’s instructions exactly.
• If you miss a dose, ask your pharmacist what to do.
• Never take two tablets in one day to make up for a missed dose.
• Do not change the dose without medical advice.

Side Effects of Lipaglyn 4 mg

Lipaglyn 4 mg side effects reported in clinical studies were mostly mild.

Common Side Effects

• Stomach upset or gastritis
• Tiredness or weakness
• Fever
• Dizziness
• Nausea

Serious Side Effects (Seek Immediate Medical Attention)

• Swelling in the feet or ankles
• Noticeable or rapid weight gain
• Chest pain or trouble breathing

See your GP or pharmacist if side effects persist or worry you. For chest pain, trouble breathing or severe swelling.

Drug Interactions

Tell your prescriber and pharmacist about all medicines, supplements and herbal therapies you take.

Medicines That May Interact

• Insulin and other glucose-lowering medicines
• Statins
• Fibrates
• Medicines that affect liver enzymes
• Medicines that affect kidney function

Keep an up-to-date list of your medicines and ask before adding any new one, including online or overseas products. Do not change alcohol intake, diabetes or cholesterol treatment without discussing it with your clinician.

Storage and Handling Instructions

• Store in the original pack, away from heat, moisture, and direct sunlight.
• Keep out of reach and sight of children.
• Check the expiry date and avoid damaged, loose, or discoloured tablets.
• Ask a pharmacist how to dispose of unused or expired tablets safely.
• Follow the exact storage conditions printed on your pack.

Precautions Before Starting Lipaglyn

Before starting, tell your doctor about any liver or kidney disease, diabetes, heart disease, gallbladder problems, allergies or unexplained swelling, and share any recent test results.

Tell your doctor if you are pregnant, planning pregnancy or breastfeeding. Safety in pregnancy is not established, so only start or continue treatment on a clinician’s advice.

If sourcing this medicine online, verify the seller’s pharmacist details and Australian contact before paying — GenericMedsAustralia.com can help you check a supplier’s credentials.

Tips for Getting the Best Results from Lipaglyn

• Attend follow-ups and complete requested liver, kidney, glucose and lipid tests.
• Eat well, limit added sugar, and follow your GP’s or dietitian’s advice.
• Increase physical activity gradually if you are new to exercise.
• Take doses consistently and use a reminder if you often forget.
• Report new symptoms promptly rather than waiting for your next appointment.

Conclusion

Lipaglyn 4 mg (Saroglitazar) is used for specific, doctor-directed conditions such as NAFLD, NASH and diabetic dyslipidaemia. Sourced through a legitimate pharmacy and used under medical supervision, it can play a useful role in a broader treatment plan — always consult your GP or pharmacist about diagnosis, monitoring and interactions.

FAQs